相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GV1001 Induces Apoptosis by Reducing Angiogenesis in Renal Cell Carcinoma Cells Both In Vitro and In Vivo
Ga Eun Kim et al.
UROLOGY (2018)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2017)
De Novo Design and Synthesis of a -Turn Peptidomimetic Scaffold and Its Application as JNK3 Allosteric Ligand
Mi-hyun Kim et al.
CHEMISTRY-AN ASIAN JOURNAL (2015)
Tumor-suppressive effect of a telomerase-derived peptide by inhibiting hypoxia-induced HIF-1α-VEGF signaling axis
Bu-Kyung Kim et al.
BIOMATERIALS (2014)
Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancer
Niels Eckstein et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist
Peter C. Albertsen et al.
EUROPEAN UROLOGY (2014)
Disease Control Outcomes from Analysis of Pooled Individual Patient Data from Five Comparative Randomised Clinical Trials of Degarelix Versus Luteinising Hormone-releasing Hormone Agonists
Laurence Klotz et al.
EUROPEAN UROLOGY (2014)
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton et al.
LANCET ONCOLOGY (2014)
Degarelix versus Goserelin plus Bicalutamide Therapy for Lower Urinary Tract Symptom Relief, Prostate Volume Reduction and Quality of Life Improvement in Men with Prostate Cancer: A Systematic Review and Meta-Analysis
Yuanshan Cui et al.
UROLOGIA INTERNATIONALIS (2014)
Heat shock protein-mediated cell penetration and cytosolic delivery of macromolecules by a telomerase-derived peptide vaccine
Seoung-Ae Lee et al.
BIOMATERIALS (2013)
Combined androgen blockade for prostate cancer: Review of efficacy, safety and cost-effectiveness
Hideyuki Akaza
CANCER SCIENCE (2011)
Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients
Jon Amund Kyte et al.
CLINICAL CANCER RESEARCH (2011)
Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
Paal Fr. Brunsvig et al.
CLINICAL CANCER RESEARCH (2011)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Nicolas Mottet et al.
EUROPEAN UROLOGY (2011)
Characterising the castration-resistant prostate cancer population: a systematic review
M. Kirby et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Update on castrate-resistant prostate cancer: 2010
Kiran Lassi et al.
CURRENT OPINION IN ONCOLOGY (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80 mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics
Bertrand Tombal et al.
EUROPEAN UROLOGY (2010)
Signaling Responses to Pulsatile Gonadotropin-releasing Hormone in LβT2 Gonadotrope Cells
Rie Tsutsumi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Gonadotropin-Releasing Hormone Type II Induces Apoptosis of Human Endometrial Cancer Cells by Activating GADD45α
Hsien-Ming Wu et al.
CANCER RESEARCH (2009)
Cancer vaccination with telomerase peptide GV1001
Jon Amund Kyte
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
GnRH signaling in intrauterine tissues
Hsien-Ming Wu et al.
REPRODUCTION (2009)
Gonadotropin Releasing Hormone Analogs Induce Apoptosis by Extrinsic Pathway Involving p53 Phosphorylation in Primary Cell Cultures of Human Prostatic Adenocarcinomas
Marisa Clementi et al.
PROSTATE (2009)
The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
Laurence Klotz et al.
BJU INTERNATIONAL (2008)
Hydrophobic, hydrophilic, and charged amino acid networks within protein
Md. Aftabuddin et al.
BIOPHYSICAL JOURNAL (2007)
Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study
S. L. Bernhardt et al.
BRITISH JOURNAL OF CANCER (2006)
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
Paal F. Brunsvig et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Gonadotropin-releasing hormone in apoptosis of prostate cancer cells
S Kraus et al.
CANCER LETTERS (2006)
GnRHs and GnRH receptors
RP Millar
ANIMAL REPRODUCTION SCIENCE (2005)
Signaling and antiproliferative effects of type I and II gonadotropin-releasing hormone receptors in breast cancer cells
AR Finch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells:: Role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways
S Kraus et al.
CANCER RESEARCH (2004)
Proliferation of TSU-Prl, a human prostatic carcinoma cell line is stimulated by gonadotropin-releasing hormone
M Enomoto et al.
LIFE SCIENCES (2004)
Structure of the GnRH receptor-stimulated signaling network: insights from genomics
F Ruf et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2003)
An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion
LZ Krsmanovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hormonal therapy: Historical perspective to future directions
DG McLeod
UROLOGY (2003)
Involvement of both Gq/11 and Gs proteins in gonadotropin-releasing hormone receptor-mediated signaling in LβT2 cells
FJ Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers:: Frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues
P Völker et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2002)
分享论文
